Benoit I, Di Curzio D, Civetta A, Douville R
Cells. 2022; 11(17).
PMID: 36078091
PMC: 9454636.
DOI: 10.3390/cells11172685.
Lambert G, Upadhyay C
Vaccines (Basel). 2021; 9(2).
PMID: 33669676
PMC: 7922494.
DOI: 10.3390/vaccines9020176.
Medina L, To A, Lieberman M, Wong T, Namekar M, Nakano E
Front Immunol. 2018; 9:2464.
PMID: 30467501
PMC: 6236113.
DOI: 10.3389/fimmu.2018.02464.
Vallbracht M, Brun D, Tassinari M, Vaney M, Pehau-Arnaudet G, Guardado-Calvo P
J Virol. 2017; 92(1).
PMID: 29046441
PMC: 5730762.
DOI: 10.1128/JVI.01203-17.
Uribe E, Venkatesan M, Rose D, Ewart K
Cytotechnology. 2012; 65(4):513-21.
PMID: 23076800
PMC: 3720964.
DOI: 10.1007/s10616-012-9505-7.
HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism.
Tuzer F, Madani N, Kamanna K, Zentner I, LaLonde J, Holmes A
Proteins. 2012; 81(2):271-90.
PMID: 23011758
PMC: 3731144.
DOI: 10.1002/prot.24184.
HIV-1 virus-like particles produced by stably transfected Drosophila S2 cells: a desirable vaccine component.
Yang L, Song Y, Li X, Huang X, Liu J, Ding H
J Virol. 2012; 86(14):7662-76.
PMID: 22553333
PMC: 3416305.
DOI: 10.1128/JVI.07164-11.
T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines.
Pusic K, Hashimoto C, Lehrer A, Aniya C, Clements D, Hui G
PLoS One. 2011; 6(9):e24782.
PMID: 21931852
PMC: 3172285.
DOI: 10.1371/journal.pone.0024782.
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.
Coller B, Clements D, Bett A, Sagar S, Ter Meulen J
Vaccine. 2011; 29(42):7267-75.
PMID: 21777637
PMC: 3179979.
DOI: 10.1016/j.vaccine.2011.07.021.
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.
Clements D, Coller B, Lieberman M, Ogata S, Wang G, Harada K
Vaccine. 2010; 28(15):2705-15.
PMID: 20097152
PMC: 2837772.
DOI: 10.1016/j.vaccine.2010.01.022.
Expression of the hepatitis B virus surface antigen in Drosophila S2 cells.
Jorge S, Santos A, Spina A, Pereira C
Cytotechnology. 2008; 57(1):51-9.
PMID: 19003172
PMC: 2553638.
DOI: 10.1007/s10616-008-9154-z.
Improving heterologous protein expression in transfected Drosophila S2 cells as assessed by EGFP expression.
Santos M, Jorge S, Brillet K, Pereira C
Cytotechnology. 2008; 54(1):15-24.
PMID: 19003014
PMC: 2267513.
DOI: 10.1007/s10616-007-9060-9.
Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1.
Gopi H, Umashankara M, Pirrone V, LaLonde J, Madani N, Tuzer F
J Med Chem. 2008; 51(9):2638-47.
PMID: 18402432
PMC: 2921370.
DOI: 10.1021/jm070814r.
Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus.
Xie H, Ng D, Savinov S, Dey B, Kwong P, Wyatt R
J Med Chem. 2007; 50(20):4898-908.
PMID: 17803292
PMC: 2532594.
DOI: 10.1021/jm070564e.
Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.
Lieberman M, Clements D, Ogata S, Wang G, Corpuz G, Wong T
Vaccine. 2006; 25(3):414-23.
PMID: 16996661
PMC: 1839850.
DOI: 10.1016/j.vaccine.2006.08.018.
Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: characterization and ligand binding analysis.
Pancera M, Lebowitz J, Schon A, Zhu P, Freire E, Kwong P
J Virol. 2005; 79(15):9954-69.
PMID: 16014956
PMC: 1181572.
DOI: 10.1128/JVI.79.15.9954-9969.2005.
Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1.
Yang X, Tomov V, Kurteva S, Wang L, Ren X, Gorny M
J Virol. 2004; 78(23):12975-86.
PMID: 15542649
PMC: 525028.
DOI: 10.1128/JVI.78.23.12975-12986.2004.
Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid.
Muerhoff A, Dawson G, Dille B, Gutierrez R, Leary T, Gupta M
Clin Diagn Lab Immunol. 2004; 11(4):651-7.
PMID: 15242936
PMC: 440607.
DOI: 10.1128/CDLI.11.4.651-657.2004.
Energetics of the HIV gp120-CD4 binding reaction.
Myszka D, Sweet R, HENSLEY P, Brigham-Burke M, Kwong P, Hendrickson W
Proc Natl Acad Sci U S A. 2000; 97(16):9026-31.
PMID: 10922058
PMC: 16815.
DOI: 10.1073/pnas.97.16.9026.
HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation.
Liu Q, Williams D, McManus C, Baribaud F, Doms R, Schols D
Proc Natl Acad Sci U S A. 2000; 97(9):4832-7.
PMID: 10758170
PMC: 18318.
DOI: 10.1073/pnas.090521697.